Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIN1 | Q13526 | 4/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 6/20 | 0.37 |
| ▸ | PDE5A | O76074 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.35 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27174482 | 1.00 | PIN1 (0.38) | PIN1PRKCQPDE5ANPC1PDE4B | |
| SCHEMBL27031390 | 0.88 | USP1 (0.42) | PIN1PRKCQNPC1PDE4BPDE3A | |
| SCHEMBL29878746 | 0.88 | USP1 (0.42) | PIN1PRKCQNPC1PDE4BPDE3A | |
| SCHEMBL27174345 | 0.85 | USP1 (0.36) | PDE5APDE4BPDE3A | |
| SCHEMBL29878920 | 0.84 | PRKCQ (0.37) | PIN1PRKCQNPC1PDE4BPDE3A | |
| SCHEMBL27031660 | 0.84 | PRKCQ (0.37) | PIN1PRKCQNPC1PDE4BPDE3A | |
| SCHEMBL29878665 | 0.82 | PRKCQ (0.40) | PIN1PRKCQNPC1 | |
| SCHEMBL27031673 | 0.82 | PRKCQ (0.40) | PIN1PRKCQNPC1 | |
| SCHEMBL30677054 | 0.80 | PRKCQ (0.38) | PIN1PRKCQNPC1 | |
| SCHEMBL30461982 | 0.80 | STIM1 (0.41) | PDE5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4547336-A1 | USP1 INHIBITORS AND USES THEREOF | Zentaur Therapeutics USA Inc. (US) | 2025-05-07 | — | — | EP | disclosed |
| CN-119836421-A | USP1 inhibitors and uses thereof | 森韬医药美国公司 | 2025-04-15 | — | — | CN | disclosed |
| WO-2024006879-A1 | USP1 INHIBITORS AND USES THEREOF | ZENTAUR THERAPEUTICS USA INC. (US) | 2024-01-04 | — | — | WO | disclosed |